bullish
Burning Rock (传奇生物) IPO: Sentiment Matters
344 Views08 Jun 2020 14:49
Burning Rock, a leading precision oncology player in China, started book building to raise up to USD 235 million (including concurrent private...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Burning Rock Biotech (BNR US): Attractive Growth Story Outshined by Surging COVID Cases in China31 Mar 2022
- Burning Rock Biotech (BNR US): Muted Near-Term Outlook on Resurgence of COVID-19 in China07 Nov 2021
- Burning Rock (燃石医学) IPO Trading: Hot Deal, Small Float12 Jun 2020
- Burning Rock (燃石医学) Pre-IPO: Thoughts on Valuation04 Jun 2020
- Burning Rock (燃石医学) Pre-IPO: Leading Precision Oncology Player but Short of Disclosure29 May 2020
x